CSF1R and breast carcinoma: Our previous breast cancer studies found that CSF-1/CSF-1R signaling promotes tumor growth [8] [9, 10] and it has been demonstrated that CSF-1R blockade using antibodies reduced the number of resident tumor-associated macrophages (TAMs) in tumors [11].